Skip to main content

Bollard Group LLC

SEC CIK
0001556218
Latest filing
Aug 12, 2026

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Bollard Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2025
Holdings of CLDX by Bollard Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−19,627−100.0%Sold outHolders
Q2 202519,627$399.0K<0.1%+19,627NewHolders